Roth Boosts PT on TG Therapeutics (TGTX) to $33 on Strong ASH Showing, Buyout Prospects
Tweet Send to a Friend
Roth Capital boosts its price target on TG Therapeutics (Nasdaq: TGTX) from $25 to $33 and maintains a Buy/Focus Pick ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
